InvestorsHub Logo
Followers 6
Posts 182
Boards Moderated 0
Alias Born 09/16/2010

Re: None

Monday, 06/07/2021 7:54:24 AM

Monday, June 07, 2021 7:54:24 AM

Post# of 469766
Most scientists want a complete trial to see, not partial-not even statistically significant since the number of patients is very small- results.
Even if its for Rett, Parkinson's or anything.
I think that their opinion on sigma-1's antioxidative stress properties, autophagy, mitochondrial or any other effect are theories not facts.
Something like the vitamin mania that many people (even scientists) believed in the past that actually does not offer much to health improvement something that we know now.
If one day we see complete statistically significant results then they will
start changing their mind that there exists alternative ways to improve
therapeutic options on these devastating diseases.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News